QuickView for CDK5;jsessionid=DF00B73361DF4175895E59E85F89AE6E;jsessionid=6E26CFFE097EA8D16F835AEF70BA318B;jsessionid=2CA4BCE8AB570DA75516FD0B3CAC2083;jsessionid=B2D88DDB50F1775BE51EE2A961C76A94;jsessionid=FF7B3F62304B316384DB5E817ECBA370 (gene)

1. Cyclin-dependent kinase 5 (CDK5) inhibitors in Parkinson disease.
2. Phosphorylation of PBK at Thr9 by CDK5 correlates with invasion of prolactinomas.
3. Maintaining Drosha expression with Cdk5 inhibitors as a potential therapeutic strategy for early int…
4. Novel Medicinal Chemistry Strategies Targeting CDK5 for Drug Discovery.
5. Activation of cyclin-dependent kinase 5 broadens action potentials in human sensory neurons.

There were no clinical trials for CDK5;jsessionid=DF00B73361DF4175895E59E85F89AE6E;jsessionid=6E26CFFE097EA8D16F835AEF70BA318B;jsessionid=2CA4BCE8AB570DA75516FD0B3CAC2083;jsessionid=B2D88DDB50F1775BE51EE2A961C76A94;jsessionid=FF7B3F62304B316384DB5E817ECBA370